134 related articles for article (PubMed ID: 9816221)
21. Structural design, biochemical properties, and evidence for improved therapeutic activity of 5-alkyl derivatives of 5-deazaaminopterin and 5-deazamethotrexate compared to methotrexate in murine tumor models.
Sirotnak FM; Schmid FA; Otter GM; Piper JR; Montgomery JA
Cancer Res; 1988 Oct; 48(20):5686-91. PubMed ID: 3167828
[TBL] [Abstract][Full Text] [Related]
22. New folate analogs of the 10-deaza-aminopterin series: markedly increased antitumor activity of the 10-ethyl analog compared to the parent compound and methotrexate against some human tumor xenografts in nude mice.
Schmid FA; Sirotnak FM; Otter GM; DeGraw JI
Cancer Treat Rep; 1985 May; 69(5):551-3. PubMed ID: 4005878
[TBL] [Abstract][Full Text] [Related]
23. Phase I trial of 10-deaza-aminopterin in patients with advanced cancer.
Currie VE; Warrell RP; Arlin Z; Tan C; Sirotnak FM; Greene G; Young CW
Cancer Treat Rep; 1983 Feb; 67(2):149-54. PubMed ID: 6825121
[TBL] [Abstract][Full Text] [Related]
24. Intracavitary therapy of murine ovarian cancer with cis-diamminedichloroplatinum(II) and 10-ethyl-10-deazaaminopterin incorporating systemic leucovorin protection.
Sirotnak FM; Schmid FA; DeGraw JI
Cancer Res; 1989 Jun; 49(11):2890-3. PubMed ID: 2785847
[TBL] [Abstract][Full Text] [Related]
25. Inhibitory action of 10-deazaaminopterins and their polyglutamates on human thymidylate synthase.
Ueda T; Dutschman GE; Nair MG; Degraw JI; Sirotnak FM; Cheng YC
Mol Pharmacol; 1986 Aug; 30(2):149-53. PubMed ID: 2426568
[TBL] [Abstract][Full Text] [Related]
26. Regiospecific gamma-conjugation of methotrexate to poly(L-lysine). Chemical and biological studies.
Rosowsky A; Forsch RA; Galivan J; Susten SS; Freisheim JH
Mol Pharmacol; 1985 Jan; 27(1):141-7. PubMed ID: 3965926
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and potent antifolate activity and cytotoxicity of B-ring deaza analogues of the nonpolyglutamatable dihydrofolate reductase inhibitor Nalpha-(4-amino-4-deoxypteroyl)-Ndelta-hemiphthaloyl- L-ornithine (PT523).
Rosowsky A; Wright JE; Vaidya CM; Bader H; Forsch RA; Mota CE; Pardo J; Chen CS; Chen YN
J Med Chem; 1998 Dec; 41(26):5310-9. PubMed ID: 9857098
[TBL] [Abstract][Full Text] [Related]
28. Activity of the folate analog 10-ethyl, 10-deaza-aminopterin (10-EdAM) against human head and neck cancer xenografts.
Brown DH; Braakhuis BJ; van Dongen GA; van Walsum M; Bagnay M; Snow GB
Anticancer Res; 1989; 9(6):1549-52. PubMed ID: 2627109
[TBL] [Abstract][Full Text] [Related]
29. Polyglutamylation, an important element in methotrexate cytotoxicity and selectivity in tumor versus murine granulocytic progenitor cells in vitro.
Fabre I; Fabre G; Goldman ID
Cancer Res; 1984 Aug; 44(8):3190-5. PubMed ID: 6204743
[TBL] [Abstract][Full Text] [Related]
30. Antifolate analogs: mechanism of action, analytical methodology, and clinical efficacy.
Fleisher M
Ther Drug Monit; 1993 Dec; 15(6):521-6. PubMed ID: 8122287
[TBL] [Abstract][Full Text] [Related]
31. Methotrexate-induced cytotoxicity and genotoxicity in germ cells of mice: intervention of folic and folinic acid.
Padmanabhan S; Tripathi DN; Vikram A; Ramarao P; Jena GB
Mutat Res; 2009 Feb; 673(1):43-52. PubMed ID: 19110071
[TBL] [Abstract][Full Text] [Related]
32. Reduced forms of aminopterin and methotrexate in L1210 lymphoma.
Makulu DR; Fölsch E
J Natl Cancer Inst; 1977 Jul; 59(1):245-9. PubMed ID: 875056
[TBL] [Abstract][Full Text] [Related]
33. Experimental therapeutics with a new 10-deazaaminopterin in human mesothelioma: further improving efficacy through structural design, pharmacologic modulation at the level of MRP ATPases, and combined therapy with platinums.
Khokhar NZ; She Y; Rusch VW; Sirotnak FM
Clin Cancer Res; 2001 Oct; 7(10):3199-205. PubMed ID: 11595715
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and in vitro antifolate activity of rotationally restricted aminopterin and methotrexate analogues.
Rosowsky A; Forsch RA; Wright JE
J Med Chem; 2004 Dec; 47(27):6958-63. PubMed ID: 15615544
[TBL] [Abstract][Full Text] [Related]
35. Analogues of methotrexate and aminopterin with gamma-methylene and gamma-cyano substitution of the glutamate side chain: synthesis and in vitro biological activity.
Rosowsky A; Bader H; Freisheim JH
J Med Chem; 1991 Jan; 34(1):203-8. PubMed ID: 1992118
[TBL] [Abstract][Full Text] [Related]
36. Metabolism-blocked antifolates as potential anti-rheumatoid arthritis agents: 4-amino-4-deoxy-5,8,10-trideazapteroyl-d,l-4'-methyleneglutamic acid (CH-1504) and its analogs.
McGuire JJ; Haile WH
Biochem Pharmacol; 2009 Apr; 77(7):1161-72. PubMed ID: 19174154
[TBL] [Abstract][Full Text] [Related]
37. New thiophene substituted 10-deazaaminopterins: synthesis and biological evaluation.
Abraham A; McGuire JJ; Galivan J; Vishnuvajjala BR; Nair MG
Adv Exp Med Biol; 1993; 338():421-4. PubMed ID: 8304149
[TBL] [Abstract][Full Text] [Related]
38. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate.
Zhao R; Babani S; Gao F; Liu L; Goldman ID
Clin Cancer Res; 2000 Sep; 6(9):3687-95. PubMed ID: 10999762
[TBL] [Abstract][Full Text] [Related]
39. Novel 8-deaza-5,6,7,8-tetrahydroaminopterin derivatives as dihydrofolate inhibitor: design, synthesis and antifolate activity.
Zhang Z; Wu J; Ran F; Guo Y; Tian R; Zhou S; Wang X; Liu Z; Zhang L; Cui J; Liu J
Eur J Med Chem; 2009 Feb; 44(2):764-71. PubMed ID: 18555562
[TBL] [Abstract][Full Text] [Related]
40. Cyclic hydroxamic-acid-containing peptide 31, a potent synthetic histone deacetylase inhibitor with antitumor activity.
Komatsu Y; Tomizaki KY; Tsukamoto M; Kato T; Nishino N; Sato S; Yamori T; Tsuruo T; Furumai R; Yoshida M; Horinouchi S; Hayashi H
Cancer Res; 2001 Jun; 61(11):4459-66. PubMed ID: 11389076
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
